00000nam 2200000za 4500 9.847509 CaOODSP 20221107153446 cr ||||||||||| 171121s2018 onc o f000 0 eng d 9780660239293 9780660239309 CaOODSP eng n-cn--- NR16-172/2017E-PDF Synthetic archaeosome adjuvants for improved vaccine formulation (L-11784) [electronic resource]. [Ottawa] : National Research Council Canada, [2018] [1] p. Issued also in French under title: Adjuvants d’archéosomes synthétiques pour améliorer la préparation de vaccins (L-11784). Caption title. "January 2017." “Vaccine adjuvants are immune stimulating compounds that, when combined with antigens, enhance the magnitude, the quality and/or the duration of immune responses. Though adjuvants play a central role in vaccination, few non-toxic adjuvants are currently available to vaccine developers. To address this need, the NRC has developed synthetic archaeal lipids for the production of well-defined, tailor-made, non-toxic and thermostable adjuvants that can be can combined with a wide range of antigens. The NRC’s synthetic archaeosomes have both immunomodulating and antigen-delivery adjuvant properties. They can be customized to evoke specific immune responses that are long and durable”--Highlights. Issued also in print format. Immunological adjuvants Liposomes National Research Council Canada. Adjuvants d’archéosomes synthétiques pour améliorer la préparation de vaccins (L-11784) (CaOODSP)9.847512 Synthetic archaeosome adjuvants for improved vaccine formulation (CaOODSP)9.847511 PDF 116 KB https://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-172-2017-eng.pdf